Marken And Globalcare Leading The Direct To Patient Market

Co-Marketing Relationship Brings Clinical Trials to Patient Homes Worldwide

Marken announced recently that its relationship with GlobalCare Clinical Trials has expanded to include 80 active trials in 45 countries, making the two companies clear leaders in the growing direct to patient (DTP) market. Demand for DTP services is increasing as pharma seeks new avenues to recruit and retain patients around the globe.

Marken’s Direct to Patient (DTP) home delivery service provides delivery of clinical trial materials directly to a patient’s home and retrieves the biological specimens for testing, with quality guaranteed through full temperature monitoring (when required) from pick up to delivery. Marken’s project management and courier services are combined with GlobalCare’s extensive nursing services to offer a comprehensive home-based solution. GlobalCare conducts study visits at patients' homes by mobilizing their global network of traveling nurses and clinicians who are experienced in multiple therapeutic areas and all age groups. Marken and GlobalCare work together through the use of comprehensive Standard Operating Procedures (SOPs) which have been audited by clients. More importantly, the two companies help sponsors to assess the regulatory feasibility as well as logistical implementation of home-based clinical trial services in particular countries. Dedicated project managers, as well as a network of multilingual and ICH-GCP certified Country Coordinators, are assigned to oversee and coordinate the trial DTP services. The GlobalCare nurses are then locally assigned to patients and team up with Marken’s couriers to make the home visit a seamless process with minimal travel time for the home healthcare providers.

Marken and GlobalCare together lead the industry in both the depth and breadth of their global network. Both companies have developed excellent reputations for service and quality and both are 100% dedicated to serving the clinical trials industry. Recently, Marken was the first and only logistics provider granted permission by the government to deliver the first direct to patient shipment of drug product in South Korea. This precedent-setting shipment allowed several patients in South Korea to continue receiving their drugs during the outbreak of Middle East Respiratory Syndrome (MERS).

Wes Wheeler, Marken’s CEO, commented, “Marken has been very pleased with our growing relationship with GlobalCare. We have worked together for three years and it has been a great experience learning from each other as we develop this important market. We share many of the corporate values of quality, flexibility, service and compliance, and we are both 100% dedicated to clinical trials. These are all important factors when a client is searching for a partner in DTP services.”

“We are very excited about our expanding and synergistic relationship with Marken,” stated Gail Adinamis, founder and CEO of GlobalCare. “The similarities in our culture and values allow us to quickly integrate our logistics on a global basis. Our patient-centric services provide a convenient way for patients to participate in trials resulting in faster recruitment and better compliance and retention,” continued Adinamis.

Marken and GlobalCare have been invited to speak on the Direct to Patient topic at over 30 workshops within the pharma industry, often held on-site at the pharma company to provide team access to case studies, solutions, and patient-centric models addressing geography, demographics, and drug storage conditions. 

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies.

About GlobalCare
GlobalCare Clinical Trials, Ltd is a global niche service provider offering a patient-centric service model that provides selected clinical study visits in the home or alternate setting. Services are provided in over 40 countries through an extensive network of multilingual Country Coordinators and local highly skilled ambulant clinicians. For more information, visit www.globalcarect.com.